Verge - Model ConVERGE - Drug Discovery Platform
The breadth and depth of our pipeline demonstrates the power of the ConVERGEMplatform. All pipeline programs have been discovered and developed on our proprietary platform.
-
Most popular related searches
Details
The ConVERGETM platform addresses diseases where biology is the bottleneck. Our programs target therapeutic areas where:
- Multi-factorial components (genetics, environment, and time) intersect in complex ways to culminate in overt disease
- Animal or cell models do not predict human efficacy
- There is high unmet need, no disease-modifying therapies, or significant shortcomings with existing treatment paradigms
From novel target to clinical candidate on one pla...
Approach
Our end-to-end ConVERGETM discovery platform is a closed-loop machine learning system combining industry-leading proprietary human genomics with advanced computational tools to predict new drugs with a higher probability of clinical success.
Our end-to-end ConVERGETM discovery platform is a closed-loop machine learning system combining industry-leading proprietary human genomics with advanced computational tools to predict new drugs with a higher probability of clinical success.
Customer reviews
No reviews were found for Verge - Model ConVERGE - Drug Discovery Platform. Be the first to review!